These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 32323609)
1. Phase I/II Study of Intrathecal Administration of Recombinant Human Hepatocyte Growth Factor in Patients with Acute Spinal Cord Injury: A Double-Blind, Randomized Clinical Trial of Safety and Efficacy. Nagoshi N; Tsuji O; Kitamura K; Suda K; Maeda T; Yato Y; Abe T; Hayata D; Matsumoto M; Okano H; Nakamura M J Neurotrauma; 2020 Aug; 37(15):1752-1758. PubMed ID: 32323609 [TBL] [Abstract][Full Text] [Related]
2. Granulocyte-colony stimulating factor administration for neurological improvement in patients with postrehabilitation chronic incomplete traumatic spinal cord injuries: a double-blind randomized controlled clinical trial. Derakhshanrad N; Saberi H; Yekaninejad MS; Joghataei MT; Sheikhrezaei A J Neurosurg Spine; 2018 Jul; 29(1):97-107. PubMed ID: 29701561 [TBL] [Abstract][Full Text] [Related]
3. Randomized trial of granulocyte colony-stimulating factor for spinal cord injury. Koda M; Hanaoka H; Fujii Y; Hanawa M; Kawasaki Y; Ozawa Y; Fujiwara T; Furuya T; Ijima Y; Saito J; Kitamura M; Miyamoto T; Ohtori S; Matsumoto Y; Abe T; Takahashi H; Watanabe K; Hirano T; Ohashi M; Shoji H; Mizouchi T; Kawahara N; Kawaguchi M; Orita Y; Sasamoto T; Yoshioka M; Fujii M; Yonezawa K; Soma D; Taneichi H; Takeuchi D; Inami S; Moridaira H; Ueda H; Asano F; Shibao Y; Aita I; Takeuchi Y; Mimura M; Shimbo J; Someya Y; Ikenoue S; Sameda H; Takase K; Ikeda Y; Nakajima F; Hashimoto M; Hasue F; Fujiyoshi T; Kamiya K; Watanabe M; Katoh H; Matsuyama Y; Hasegawa T; Yoshida G; Arima H; Yamato Y; Oe S; Togawa D; Kobayashi S; Akeda K; Kawamoto E; Imai H; Sakakibara T; Sudo A; Ito Y; Kikuchi T; Takigawa T; Morita T; Tanaka N; Nakanishi K; Kamei N; Kotaka S; Baba H; Okudaira T; Konishi H; Yamaguchi T; Ito K; Katayama Y; Matsumoto T; Matsumoto T; Kanno H; Aizawa T; Hashimoto K; Eto T; Sugaya T; Matsuda M; Fushimi K; Nozawa S; Iwai C; Taguchi T; Kanchiku T; Suzuki H; Nishida N; Funaba M; Sakai T; Imajo Y; Yamazaki M Brain; 2021 Apr; 144(3):789-799. PubMed ID: 33764445 [TBL] [Abstract][Full Text] [Related]
4. Safety, Tolerability, and Pharmacodynamics of Intrathecal Injection of Recombinant Human HGF (KP-100) in Subjects With Amyotrophic Lateral Sclerosis: A Phase I Trial. Warita H; Kato M; Asada R; Yamashita A; Hayata D; Adachi K; Aoki M J Clin Pharmacol; 2019 May; 59(5):677-687. PubMed ID: 30536581 [TBL] [Abstract][Full Text] [Related]
5. Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury. Casha S; Zygun D; McGowan MD; Bains I; Yong VW; Hurlbert RJ Brain; 2012 Apr; 135(Pt 4):1224-36. PubMed ID: 22505632 [TBL] [Abstract][Full Text] [Related]
6. Application of Hepatocyte Growth Factor for Acute Spinal Cord Injury: The Road from Basic Studies to Human Treatment. Kitamura K; Nagoshi N; Tsuji O; Matsumoto M; Okano H; Nakamura M Int J Mol Sci; 2019 Feb; 20(5):. PubMed ID: 30823442 [TBL] [Abstract][Full Text] [Related]
7. Neurological and functional status 1 year after acute spinal cord injury: estimates of functional recovery in National Acute Spinal Cord Injury Study II from results modeled in National Acute Spinal Cord Injury Study III. Bracken MB; Holford TR J Neurosurg; 2002 Apr; 96(3 Suppl):259-66. PubMed ID: 11990832 [TBL] [Abstract][Full Text] [Related]
8. Multicenter prospective nonrandomized controlled clinical trial to prove neurotherapeutic effects of granulocyte colony-stimulating factor for acute spinal cord injury: analyses of follow-up cases after at least 1 year. Inada T; Takahashi H; Yamazaki M; Okawa A; Sakuma T; Kato K; Hashimoto M; Hayashi K; Furuya T; Fujiyoshi T; Kawabe J; Mannoji C; Miyashita T; Kadota R; Someya Y; Ikeda O; Hashimoto M; Suda K; Kajino T; Ueda H; Ito Y; Ueta T; Hanaoka H; Takahashi K; Koda M Spine (Phila Pa 1976); 2014 Feb; 39(3):213-9. PubMed ID: 24299727 [TBL] [Abstract][Full Text] [Related]
9. Study protocol for the G-SPIRIT trial: a randomised, placebo-controlled, double-blinded phase III trial of granulocyte colony-stimulating factor-mediated neuroprotection for acute spinal cord injury. Koda M; Hanaoka H; Sato T; Fujii Y; Hanawa M; Takahashi S; Furuya T; Ijima Y; Saito J; Kitamura M; Ohtori S; Matsumoto Y; Abe T; Watanabe K; Hirano T; Ohashi M; Shoji H; Mizouchi T; Takahashi I; Kawahara N; Kawaguchi M; Orita Y; Sasamoto T; Yoshioka M; Fujii M; Yonezawa K; Soma D; Taneichi H; Takeuchi D; Inami S; Moridaira H; Ueda H; Asano F; Shibao Y; Aita I; Takeuchi Y; Mimura M; Shimbo J; Someya Y; Ikenoue S; Sameda H; Takase K; Ikeda Y; Nakajima F; Hashimoto M; Ozawa T; Hasue F; Fujiyoshi T; Kamiya K; Watanabe M; Katoh H; Matsuyama Y; Yamamoto Y; Togawa D; Hasegawa T; Kobayashi S; Yoshida G; Oe S; Banno T; Arima H; Akeda K; Kawamoto E; Imai H; Sakakibara T; Sudo A; Ito Y; Kikuchi T; Osaki S; Tanaka N; Nakanishi K; Kamei N; Kotaka S; Baba H; Okudaira T; Konishi H; Yamaguchi T; Ito K; Katayama Y; Matsumoto T; Matsumoto T; Idota M; Kanno H; Aizawa T; Hashimoto K; Eto T; Sugaya T; Matsuda M; Fushimi K; Nozawa S; Iwai C; Taguchi T; Kanchiku T; Suzuki H; Nishida N; Funaba M; Yamazaki M BMJ Open; 2018 May; 8(5):e019083. PubMed ID: 29730616 [TBL] [Abstract][Full Text] [Related]
10. A Randomized Controlled Trial of Local Delivery of a Rho Inhibitor (VX-210) in Patients with Acute Traumatic Cervical Spinal Cord Injury. Fehlings MG; Chen Y; Aarabi B; Ahmad F; Anderson KD; Dumont T; Fourney DR; Harrop JS; Kim KD; Kwon BK; Lingam HK; Rizzo M; Shih LC; Tsai EC; Vaccaro A; McKerracher L J Neurotrauma; 2021 Aug; 38(15):2065-2072. PubMed ID: 33559524 [TBL] [Abstract][Full Text] [Related]
11. Human hepatocyte growth factor promotes functional recovery in primates after spinal cord injury. Kitamura K; Fujiyoshi K; Yamane J; Toyota F; Hikishima K; Nomura T; Funakoshi H; Nakamura T; Aoki M; Toyama Y; Okano H; Nakamura M PLoS One; 2011; 6(11):e27706. PubMed ID: 22140459 [TBL] [Abstract][Full Text] [Related]
12. Comparison of neurological and functional outcomes after administration of granulocyte-colony-stimulating factor in motor-complete versus motor-incomplete postrehabilitated, chronic spinal cord injuries: a phase I/II study. Saberi H; Derakhshanrad N; Yekaninejad MS Cell Transplant; 2014; 23 Suppl 1():S19-23. PubMed ID: 25302604 [TBL] [Abstract][Full Text] [Related]